AT373269B - Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen - Google Patents

Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen

Info

Publication number
AT373269B
AT373269B AT0909477A AT909477A AT373269B AT 373269 B AT373269 B AT 373269B AT 0909477 A AT0909477 A AT 0909477A AT 909477 A AT909477 A AT 909477A AT 373269 B AT373269 B AT 373269B
Authority
AT
Austria
Prior art keywords
pregnadienes
pregnenes
dioxo
alpha
halogen
Prior art date
Application number
AT0909477A
Other languages
English (en)
Other versions
ATA909477A (de
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Priority to AT245582A priority Critical patent/AT377267B/de
Publication of ATA909477A publication Critical patent/ATA909477A/de
Application granted granted Critical
Publication of AT373269B publication Critical patent/AT373269B/de

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms
AT0909477A 1976-12-22 1977-12-19 Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen AT373269B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT245582A AT377267B (de) 1976-12-22 1982-06-24 Verfahren zur herstellung von neuen 3,20-dioxo7alpha-halogen-4-pregnenen und -1,4-pregnadienen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (2)

Publication Number Publication Date
ATA909477A ATA909477A (de) 1983-05-15
AT373269B true AT373269B (de) 1984-01-10

Family

ID=27115720

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0909477A AT373269B (de) 1976-12-22 1977-12-19 Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen
AT0575980A AT377566B (de) 1976-12-22 1980-11-25 Einrichtung zum verspannen von schalungsteilen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0575980A AT377566B (de) 1976-12-22 1980-11-25 Einrichtung zum verspannen von schalungsteilen

Country Status (20)

Country Link
JP (1) JPS604198B2 (de)
AR (1) AR226806A1 (de)
AT (2) AT373269B (de)
BE (1) BE862089A (de)
DE (1) DE2756550C2 (de)
DK (1) DK153494C (de)
FI (1) FI63947C (de)
FR (1) FR2384793A1 (de)
GB (1) GB1575983A (de)
HK (1) HK584A (de)
HU (1) HU179784B (de)
IE (1) IE45950B1 (de)
IL (1) IL53636A (de)
MY (1) MY8500082A (de)
NL (1) NL180479C (de)
NO (1) NO151826C (de)
NZ (1) NZ186031A (de)
PT (1) PT67432B (de)
SE (1) SE429865B (de)
SG (1) SG58683G (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
SE429865B (sv) 1983-10-03
PT67432A (en) 1978-01-01
IE45950L (en) 1978-06-22
NL7714056A (nl) 1978-06-26
FI63947C (fi) 1983-09-12
SE7714538L (sv) 1978-06-23
FR2384793A1 (fr) 1978-10-20
DE2756550C2 (de) 1986-10-16
FI63947B (fi) 1983-05-31
DK153494C (da) 1989-02-20
DK153494B (da) 1988-07-18
NL180479B (nl) 1986-10-01
IE45950B1 (en) 1983-01-12
DK569977A (da) 1978-09-28
SG58683G (en) 1985-01-11
HK584A (en) 1984-01-13
AT377566B (de) 1985-04-10
IL53636A0 (en) 1978-03-10
JPS5379850A (en) 1978-07-14
JPS604198B2 (ja) 1985-02-01
FR2384793B1 (de) 1981-11-13
ATA909477A (de) 1983-05-15
ATA575980A (de) 1982-04-15
NO774359L (no) 1978-06-23
NO151826B (no) 1985-03-04
IL53636A (en) 1983-05-15
FI773825A (fi) 1978-06-23
NL180479C (nl) 1987-03-02
PT67432B (en) 1979-05-23
GB1575983A (en) 1980-10-01
DE2756550A1 (de) 1978-07-06
MY8500082A (en) 1985-12-31
HU179784B (en) 1982-12-28
NZ186031A (en) 1984-07-31
AR226806A1 (es) 1982-08-31
BE862089A (fr) 1978-06-20
NO151826C (no) 1985-06-12

Similar Documents

Publication Publication Date Title
AT366374B (de) Verfahren zur herstellung von neuen n3substituierten 5,5-dimethylhydantoinen
AT360663B (de) Verfahren zur herstellung von neuen 6,7- -benzomorphanen
AT367401B (de) Verfahren zur herstellung von neuen 6-hydroxyalkyl-1,4-dihydropyridinverbindungen
AT356671B (de) Verfahren zur herstellung von neuen n,n'-thio- -di-carbamaten
AT364359B (de) Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen
AT354626B (de) Verfahren zur herstellung von neuen 7-acyl- amino-8-oxo-3-oxa-1-azabicyclo/4.2.0/octan-2- carbonsaeure-derivaten
AT350043B (de) Verfahren zur herstellung von neuen 3-polyhalogenaethyl-2, 2-dimethylcyclopropan- carbonsaeuren
AT354434B (de) Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen
AT355305B (de) Verfahren zur herstellung von neuen ver- aetherten, elektrolytfreien methylolamino- triazinen
AT356126B (de) Verfahren zur herstellung von 3,4-dihydro-2- -methyl-4-oxo-2h-1,2-benzothiazin-3-carboxamid- -1,1-dioxid
ATA151379A (de) Verfahren zur herstellung von neuen 9alpha,21- dihalogen-11beta,17alpha-dihydroxy-6alpha-fluor -16beta-methyl-pregna-1,4-dien-verbindungen
AT372681B (de) Verfahren zur herstellung von neuen 1,5-disubstituierter hydantoinen
AT379593B (de) Verfahren zur herstellung von neuen trans-2,3dihydro-7-methoxy-3-methyl-2-subst. phenylbenzofuranderivaten
AT350071B (de) Verfahren zur herstellung des neuen 3,5,5- trimethylhexanoyl-ferrocens
AT343624B (de) Verfahren zur herstellung von neuen n-alkyl -2,4-dinitro-6- trifluormethyldiphenylaminen
AT356815B (de) Verfahren zur herstellung von 3',4'-dideoxy- kanamycin b
AT373269B (de) Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen
ATA569677A (de) Verfahren zur herstellung von neuen substi- tuierten 2,3-alkylen-bis(oxy)bezamiden
AT377267B (de) Verfahren zur herstellung von neuen 3,20-dioxo7alpha-halogen-4-pregnenen und -1,4-pregnadienen
AT353797B (de) Verfahren zur herstellung des neuen n-2,6- dichlorphenyl-2-amino-pyrimidins
AT356125B (de) Verfahren zur herstellung von neuen 1-aryloxy- -2,3-epoxypropanen
ATA272280A (de) Verfahren zur herstellung von neuen 1,4dihydropyridinverbindungen
AT347920B (de) Verfahren zur herstellung des neuen 2,5- dichlor-4-bromphenylazo-4-chlorphenylsulfids
AT361940B (de) Verfahren zur herstellung von neuen n,n'-thio- -bis-oximcarbamaten
ATA491379A (de) Verfahren zur herstellung von neuen 2,9alpha-

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee